The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Image of the Month
Precision Micro-Optical Elements for Manufacturing of Gas Sensors using IR-Absorption
Detail view of gold covered reflector surfaces on 8"-glass-wafer.
Fraunhofer Inst. Silicon Technology, Germany
NSTI Online Community